This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: Mariko Hirozane: Innovator in Pharmaceutical Chemistry
Introduction
Mariko Hirozane is a prominent inventor based in Kanagawa, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors in the brain.
Latest Patents
Hirozane holds 2 patents related to substituted piperidine compounds. Her latest patents focus on a substituted piperidine compound that exhibits orexin type 2 receptor agonist activity. This compound is represented by a specific formula and is useful as a prophylactic or therapeutic agent for narcolepsy.
Career Highlights
Mariko Hirozane is currently associated with Takeda Pharmaceutical Company Limited, where she applies her expertise in drug development. Her work has been instrumental in advancing treatments for sleep disorders.
Collaborations
Hirozane collaborates with notable colleagues, including Tatsuhiko Fujimoto and Kentaro Rikimaru, to further enhance the research and development of innovative pharmaceutical solutions.
Conclusion
Mariko Hirozane's contributions to pharmaceutical chemistry and her innovative patents highlight her role as a key figure in the fight against narcolepsy. Her work continues to pave the way for new therapeutic options in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile